CTRI/2020/06/025767已完成未知
SOMATOSTATIN RECEPTOR BASED THERANOSTIC IN HEAD AND NECK PARAGANGLIOMA: SINGLE CENTER EXPERIENCE AND REVIEW OF LITERATURE
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Including Head and neck paraganglioma(HNPGL) with/without sympathetic paraganglioma and pheochromocytoma
- •For PRRT therapy
- •-1) High-level uptake on Ga-68 DOTATATE scan( in terms of Krenning score more than 2 and low I-131, MIBG uptake
排除标准
- •Only sPGL or only PCC
- •for PRRT Therapy
- •- 1) cytopenias in one or more cell lineages( hemoglobin <9g/dl, total leucocyte count <4000/microL),2)Functional status as determined by Karnofsky performance status less than 60% or the Eastern cooperative oncology group(ECOG) performance status score more than two.
研究者
相似试验
进行中（未招募）
不适用
Radioreceptor therapy with labeled somatostatin analogues in tumors with high expression of somatostatin receptors.Patients with tumors expressing somatostatin receptors.EUCTR2013-002605-65-ITAzienda Ospedaliera di Reggio Emilia Arcispedale S.Maria Nuova/IRCCS
进行中（未招募）
1 期
Evaluation of the expression of somatostatin receptors in DOTATOC-68Ga PET scans in patients followed for metastatic breast cancerBreast CancerCTIS2023-504458-36-02Centre Hospitalier Universitaire Grenoble Alpes25
进行中（未招募）
1 期
Combined steroid therapy in sudden hearing lossIdiopathic Sudden Sensorineural Hearing LossEUCTR2017-000658-20-HU
尚未招募
不适用
Somatostatin receptor scintigraphy in patients with multiple myeloma or plasmocytoma1003522710018865plasmacytomaMultiple myelomaNL-OMON30229niversitair Medisch Centrum Groningen45
进行中（未招募）
1 期
se of somatostatin analogue therapy as primary medical treatment of acromegaly - medical treatment of acromegalyAcromegalyEUCTR2005-004300-36-GBPlymouth Hospital NHS Trust, R&D dept10